College Health
College Health Module 1: Series Introduction and Discussing Sexual Health with Patients
This module developed collaboratively by the National Network of STD Clinical Prevention Training Centers and National Association of County & City Health Officials reviews how College Health providers can approach conversations about sexual health with patients, including trauma-informed care and consent.
Content Lead:
Zoon Wangu, MD, FAAP (she/her)
Associate Professor of Pediatrics, Division of Pediatric Infectious Diseases & Immunology, UMass Chan Medical School & UMass Memorial Children's Medical Center
Clinical Faculty, Sylvie Ratelle STD/HIV Prevention Training Center, Massachusetts Department of Public Health
Contributors:
Kevin L. Ard, MD, MPH (he/him)
Assistant Professor of Medicine, Harvard Medical School
Director, Sexual Health Clinic, Massachusetts General Hospital
Clinical Faculty, Sylvie Ratelle STD/HIV Prevention Training Center, Massachusetts Department of Public Health
Philana Liang, PA-C, MPH, SAFE (she/her)
Division of Infectious Diseases, Washington University School of Medicine
Core Program Manager, St. Louis STI/HIV Prevention Training Center
Alison Marshall, PhD, FNP-C, RN (she/her)
Boston College Connell School of Nursing
Clinical Faculty, Sylvie Ratelle STD/HIV Prevention Training Center, Massachusetts Department of Public Health
Tamara Ooms, RN, MS, FNP (she/her)
University of California San Francisco Bixby Center for Global Reproductive Health
Clinical Faculty and Program Manager, California Prevention Training Center
Duran Rutledge, BA (he/him)
Capacity Building Assistance Trainer and Technical Assistance Specialist, California Prevention Training Center
Katherine Yang, PharmD, MPH (she/her)
Co-Vice Dean, Clinical Innovation and Entrepreneurship
Professor, University of California San Francisco School of Pharmacy
Infectious Diseases Clinical Pharmacist, University of California San Francisco Medical Center
Acknowledgements:
- Suzanne M. Swierc, MPH, CHES (she/her), Director of Health Promotion & Advocacy, Ball State University, Muncie, IN
- Melissa A. Habel, MPH (she/her), Strategic Partnerships and Planning Lead, Division of STD Prevention, Centers for Disease Control and Prevention
- Rebekah Horowitz, JD, MPH (she/her), Director of STI Programs, National Association of County and City Health Officials
Disclosures:
Our content experts wish to disclose they have no financial relationship(s) with ineligible companies with the exception of Drs. Ard and Wangu. Dr. Ard receives in-kind research support from Binx Health and royalties from McGraw Hill and UpToDate. Dr. Wangu receives royalties from UpToDate, DynaMed, and Elsevier. All relevant financial relationships listed for these individuals have been mitigated.
College Health
College Health Module 2: Creating an Environment of Equitable Care
This module developed collaboratively by the National Network of STD Clinical Prevention Training Centers and National Association of County & City Health Officials discusses the concept of gender diversity and needs of LGBTQ+ youth, medical mistrust and equity gaps, creating a welcoming environment on campus, and unique aspects of STI care for college students including minors.
Content Lead:
Zoon Wangu, MD, FAAP (she/her)
Associate Professor of Pediatrics, Division of Pediatric Infectious Diseases & Immunology, UMass Chan Medical School & UMass Memorial Children's Medical Center
Clinical Faculty, Sylvie Ratelle STD/HIV Prevention Training Center, Massachusetts Department of Public Health
Contributors:
Kevin L. Ard, MD, MPH (he/him)
Assistant Professor of Medicine, Harvard Medical School
Director, Sexual Health Clinic, Massachusetts General Hospital
Clinical Faculty, Sylvie Ratelle STD/HIV Prevention Training Center, Massachusetts Department of Public Health
Philana Liang, PA-C, MPH, SAFE (she/her)
Division of Infectious Diseases, Washington University School of Medicine
Core Program Manager, St. Louis STI/HIV Prevention Training Center
Alison Marshall, PhD, FNP-C, RN (she/her)
Boston College Connell School of Nursing
Clinical Faculty, Sylvie Ratelle STD/HIV Prevention Training Center, Massachusetts Department of Public Health
Tamara Ooms, RN, MS, FNP (she/her)
University of California San Francisco Bixby Center for Global Reproductive Health
Clinical Faculty and Program Manager, California Prevention Training Center
Duran Rutledge, BA (he/him)
Capacity Building Assistance Trainer and Technical Assistance Specialist, California Prevention Training Center
Katherine Yang, PharmD, MPH (she/her)
Co-Vice Dean, Clinical Innovation and Entrepreneurship
Professor, University of California San Francisco School of Pharmacy
Infectious Diseases Clinical Pharmacist, University of California San Francisco Medical Center
Acknowledgements:
- Suzanne M. Swierc, MPH, CHES (she/her), Director of Health Promotion & Advocacy, Ball State University, Muncie, IN
- Melissa A. Habel, MPH (she/her), Strategic Partnerships and Planning Lead, Division of STD Prevention, Centers for Disease Control and Prevention
- Rebekah Horowitz, JD, MPH (she/her), Director of STI Programs, National Association of County and City Health Officials
Disclosures:
Our content experts wish to disclose they have no financial relationship(s) with ineligible companies with the exception of Drs. Ard and Wangu. Dr. Ard receives in-kind research support from Binx Health and royalties from McGraw Hill and UpToDate. Dr. Wangu receives royalties from UpToDate, DynaMed, and Elsevier. All relevant financial relationships listed for these individuals have been mitigated.
This course will cover screening for and treatment of syphilis in pregnant people, and prevention, evaluation, and treatment of congenital syphilis in infants using evidence-based best practices, case studies, and interactivity.
At the conclusion of the session, the participant should be able to:
- Describe how to diagnose and treat syphilis in a pregnant person.
- Describe how to diagnose and treat congenital syphilis in infants.
- Describe the importance of interprofessional collaboration in preventing, screening for, and treating congenital syphilis.
FACULTY/CREDENTIALS:
Josh Klein, BA, Program Coordinator, New York Presbyterian Hospital
Gowri Nagendra, MPH, Program Director, New York City STD Prevention Training Center
Natalie Neu, MD MPH, Medical Director, NYC STD Prevention Training Center; Associate Professor of Pediatrics/ Fellowship Director, Columbia University Medical Center Pediatric Infectious Disease
Jessica Steinke, MPH, Senior Program Manager, New York City STD Prevention Training Center
Jason Zucker, MD MS, Assistant Professor, Divisions of Adult and Pediatric Infectious Diseases, Columbia University Medical Center; Assistant Medical Director, New York City STD Prevention Training Center
ORIGINATION DATE: August 1, 2023
EXPIRATION DATE: August 1, 2025
HARDWARE/SOFTWARE: Computer Hardware; Internet Connection; Browser
MATERIALS: None
TARGET AUDIENCE: Physicians, Nurse Practitioners, Physician Assistants, Registered Nurses, and other healthcare professionals who provide clinical care for patients with STIs.
PREREQUISITES: The audience should provide clinical care for patients with STIs.
FORMAT: This activity is Web-based/Web on Demand.
CONTACT INFORMATION: NYC STD Prevention Training Center, nycptc@cumc.columbia.edu
ACCREDITATION STATEMENTS:
|
|
In support of improving patient care, this activity has been planned and implemented by Centers for Disease Control and Prevention and The NYC STD Prevention Training Center. The Centers for Disease Control and Prevention is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
|
CME: The Centers for Disease Control and Prevention designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CNE: The Centers for Disease Control and Prevention designates this activity for 1.0 nursing contact hours.
DISCLOSURE:
CDC, our planners, and content experts wish to disclose they have no financial relationship(s) with ineligible companies with the exception of Dr. Barbee and Dr. Neu. Dr. Barbee wishes to disclose research support from Nabriva, Hologic, SpeeDx, and Dr. Neu wishes to disclose research support from Melinta and Cystic Fibrosis Foundation. All relevant financial relationships listed for these individuals have been mitigated.
Content will not include any discussion of the unlabeled use of a product or a product under investigational use.
CDC did not accept financial or in-kind support from ineligible companies for this continuing education activity.
Instructions for Obtaining Continuing Education (CE)
CE instructions are provided after the completion of this course.
FEES: No fees are charged for CDC’s CE activities.
Grant Statement:
This project is supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award 1 NU62PS924586-01-00 totaling $470,000 with 100 percent funded by CDC/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government.
This course discuses Doxy-PEP - a new tool in our STI prevention toolbox. We review evidence for Doxy-PEP, clinical questions, and Doxy-PEP implementation.
This course is not accredited for continuing education.
Grant Statement:
This project is supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award 1 NU62PS924586-01-00 totaling $470,000 with 100 percent funded by CDC/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government.
This course is a comprehensive overview of taking a sexual history. It covers rationale for why we should be taking a sexual history, how to set the stage for success, how to take an actual sexual history, and more. If you're someone who works with patients in a clinical setting, this course could be for you!
At the conclusion of the session, the participant should be able to:
1. Describe three factors which contribute to obtaining an accurate sexual history.
2. Describe two approaches to taking a sexual history.
3. Describe the importance of interprofessional collaboration in taking sexual histories.
FACULTY/CREDENTIALS:
Alwyn Cohall, MD, Principal Investigator, New York City STD Prevention Training Center; Professor of Public Health and Pediatrics, Columbia University Medical Center
Gowri Nagendra, MPH, Program Director, New York City STD Prevention Training Center
Jessica Steinke, MPH, Senior Program Manager, New York City STD Prevention Training Center
ORIGINATION DATE: August 1, 2023
EXPIRATION DATE: August 1, 2025
HARDWARE/SOFTWARE: Computer Hardware; Internet Connection; Browser
MATERIALS: None
TARGET AUDIENCE: Physicians, Nurse Practitioners, Physician Assistants, Registered Nurses, other health professionals
PREREQUISITES: The audience should provide clinical care for patients and take sexual histories.
FORMAT: This activity is Web-based/Web on Demand.
CONTACT INFORMATION: NYC STD Prevention Training Center, nycptc@cumc.columbia.edu
ACCREDITATION STATEMENTS:
|
|
In support of improving patient care, this activity has been planned and implemented by Centers for Disease Control and Prevention and The NYC STD Prevention Training Center. The Centers for Disease Control and Prevention is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team
|
CME: The Centers for Disease Control and Prevention designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CNE: The Centers for Disease Control and Prevention designates this activity for 1.0 nursing contact hours.
CEU: The Centers for Disease Control and Prevention is authorized by IACET to offer 0.1 CEU's for this program.
DISCLOSURE:
CDC, our planners, and content experts wish to disclose they have no financial relationship(s) with ineligible companies with the exception of Dr. Barbee and Dr. Neu. Dr. Barbee wishes to disclose research support from Nabriva, Hologic, SpeeDx, and Dr. Neu wishes to disclose research support from Melinta and Cystic Fibrosis Foundation. All relevant financial relationships listed for these individuals have been mitigated.
Content will not include any discussion of the unlabeled use of a product or a product under investigational use.
CDC did not accept financial or in-kind support from ineligible companies for this continuing education activity.
Instructions for Obtaining Continuing Education (CE)
CE instructions are provided after the completion of this course.
FEES: No fees are charged for CDC’s CE activities.
Grant Statement:
This project is supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award 1 NU62PS924586-01-00 totaling $470,000 with 100 percent funded by CDC/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government.
This course discusses available assistance programs for patients seeking HIV prevention who are uninsured, commercially insured, or who have Medicaid.
OBJECTIVES:
At the conclusion of the session, participants should be able to:
1. Describe HIV prevention assistance programs for uninsured patients.
2. Describe HIV prevention assistance programs for insured patients.
3. Describe the importance of interprofessional collaboration in HIV prevention benefits navigation.
FACULTY/CREDENTIALS:
Caroline Carnevale, DNP, MPH, AAHIVS, Nurse Practitioner, Principal Investigator, New York Presbyterian Hospital, Comprehensive HIV Program; Core Faculty, New York City STD Prevention Training Center
Alexandra Filipkowski, BS, MPH candidate (’24), Intern, New York City STD Prevention Training Center
Jessica Steinke, MPH, Senior Program Manager, New York City STD Prevention Training Center
ORIGINATION DATE: November 1, 2023
EXPIRATION DATE: November 1, 2025
MATERIALS: None
TARGET AUDIENCE: Physicians, Nurse Practitioners, Physician Assistants, Registered Nurses, other health professionals
PREREQUISITES: None
FORMAT: This activity is Web-based/Web on Demand.
CONTACT INFORMATION: NYC STD Prevention Training Center, nycptc@cumc.columbia.edu
ACCREDITATION STATEMENTS:
|
|
In support of improving patient care, this activity has been planned and implemented by Centers for Disease Control and Prevention and The NYC STD Prevention Training Center. The Centers for Disease Control and Prevention is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team
|
CME: The Centers for Disease Control and Prevention designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CNE: The Centers for Disease Control and Prevention designates this activity for 0.5 nursing contact hours.
CEU: The Centers for Disease Control and Prevention is authorized by IACET to offer 0.1 CEU's for this program.
DISCLOSURE:
CDC, our planners, and content experts wish to disclose they have no financial relationship(s) with ineligible companies with the exception of Dr. Barbee and Dr. Neu. Dr. Barbee wishes to disclose research support from Nabriva, Hologic, SpeeDx, and Dr. Neu wishes to disclose research support from Melinta and Cystic Fibrosis Foundation. All relevant financial relationships listed for these individuals have been mitigated.
Content will not include any discussion of the unlabeled use of a product or a product under investigational use.
CDC did not accept financial or in-kind support from ineligible companies for this continuing education activity.
Instructions for Obtaining Continuing Education (CE)
CE instructions are provided after the completion of this course.
FEES: No fees are charged for CDC’s CE activities.
Grant Statement:
This project is supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award 1 NU62PS924586-01-00 totaling $470,000 with 100 percent funded by CDC/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government.
This course discusses the current shortage of Penicillin G benzathine (Bicillin L-A). It covers the epidemiology of syphilis, how to screen for and stage syphilis, syphilis treatment guidelines, and guidelines for managing syphilis during this shortage.
This short course is not accredited for continuing education.
Grant Statement:
This project is supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award 1 NU62PS924586-01-00 totaling $470,000 with 100 percent funded by CDC/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government.
This course will review CDC's 2021 updates to the PrEP guidelines. It covers PrEP screening and assessment, available PrEP options, prescribing PrEP, and ongoing PrEP management, including case studies and interactivity.
At the conclusion of the session, participants should be able to:
-
Describe current CDC guidelines for PrEP.
- Describe clinical considerations for existing PrEP medications.
- Describe the importance of interprofessional collaboration in providing PrEP services.
FACULTY/CREDENTIALS:
Jessica Steinke, MPH, Senior Program Manager, New York City STD Prevention Training Center
Jason Zucker, MD MS, Assistant Professor, Divisions of Adult and Pediatric Infectious Diseases, Columbia University Medical Center; Assistant Medical Director, New York City STD Prevention Training Center
ORIGINATION DATE: September 1, 2023
EXPIRATION DATE: September 1, 2025
HARDWARE/SOFTWARE: Computer Hardware; Internet Connection; Browser
MATERIALS: None
TARGET AUDIENCE: Physicians, Nurse Practitioners, Physician Assistants, Registered Nurses, other health professionals
PREREQUISITES: The audience should provide clinical care for patients and discuss PrEP with patients.
FORMAT: This activity is Web-based/Web on Demand.
CONTACT INFORMATION: NYC STD Prevention Training Center, nycptc@cumc.columbia.edu
ACCREDITATION STATEMENTS:
|
|
In support of improving patient care, this activity has been planned and implemented by Centers for Disease Control and Prevention and The NYC STD Prevention Training Center. The Centers for Disease Control and Prevention is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
|
CME: The Centers for Disease Control and Prevention designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CNE: The Centers for Disease Control and Prevention designates this activity for 0.5 nursing contact hours.
CEU: The Centers for Disease Control and Prevention is authorized by IACET to offer 0.1 CEU's for this program.
DISCLOSURE:
CDC, our planners, and content experts wish to disclose they have no financial relationship(s) with ineligible companies with the exception of Dr. Barbee and Dr. Neu. Dr. Barbee wishes to disclose research support from Nabriva, Hologic, SpeeDx, and Dr. Neu wishes to disclose research support from Melinta and Cystic Fibrosis Foundation. All relevant financial relationships listed for these individuals have been mitigated.
Content will not include any discussion of the unlabeled use of a product or a product under investigational use.
CDC did not accept financial or in-kind support from ineligible companies for this continuing education activity.
Instructions for Obtaining Continuing Education (CE)
CE instructions are provided after the completion of this course.
FEES: No fees are charged for CDC’s CE activities.
Grant Statement:
This project is supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award 1 NU62PS924586-01-00 totaling $470,000 with 100 percent funded by CDC/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government.
Retail Health/Urgent Care
Retail Health/Urgent Care Module 1: Series Introduction and Discussing Sexual Health with Patients
This module developed collaboratively by the National Network of STD Clinical Prevention Training Centers and National Association of County & City Health Officials reviews how Retail Health and Urgent Care providers can approach conversations about sexual health with patients, including trauma-informed care and consent.
Content Lead:
Zoon Wangu, MD, FAAP (she/her)
Associate Professor of Pediatrics, Division of Pediatric Infectious Diseases & Immunology, UMass Chan Medical School & UMass Memorial Children's Medical Center
Clinical Faculty, Sylvie Ratelle STD/HIV Prevention Training Center, Massachusetts Department of Public Health
Contributors:
Kevin L. Ard, MD, MPH (he/him)
Assistant Professor of Medicine, Harvard Medical School
Director, Sexual Health Clinic, Massachusetts General Hospital
Clinical Faculty, Sylvie Ratelle STD/HIV Prevention Training Center, Massachusetts Department of Public Health
Philana Liang, PA-C, MPH, SAFE (she/her)
Division of Infectious Diseases, Washington University School of Medicine
Core Program Manager, St. Louis STI/HIV Prevention Training Center
Alison Marshall, PhD, FNP-C, RN (she/her)
Boston College Connell School of Nursing
Clinical Faculty, Sylvie Ratelle STD/HIV Prevention Training Center, Massachusetts Department of Public Health
Tamara Ooms, RN, MS, FNP (she/her)
University of California San Francisco Bixby Center for Global Reproductive Health
Clinical Faculty and Program Manager, California Prevention Training Center
Duran Rutledge, BA (he/him)
Capacity Building Assistance Trainer and Technical Assistance Specialist, California Prevention Training Center
Katherine Yang, PharmD, MPH (she/her)
Co-Vice Dean, Clinical Innovation and Entrepreneurship
Professor, University of California San Francisco School of Pharmacy
Infectious Diseases Clinical Pharmacist, University of California San Francisco Medical Center
Acknowledgements:
-
Nathan A. Bronstein, MPA, MsED, MSSP (he/him), Chief Operating Officer, Convenient Care Association
-
Rebekah Horowitz, JD, MPH (she/her), Director of STI Programs, National Association of County and City Health Officials
Disclosures:
Our content experts wish to disclose they have no financial relationship(s) with ineligible companies with the exception of Drs. Ard and Wangu. Dr. Ard receives in-kind research support from Binx Health and royalties from McGraw Hill and UpToDate. Dr. Wangu receives royalties from UpToDate, DynaMed, and Elsevier. All relevant financial relationships listed for these individuals have been mitigated.
Retail Health/Urgent Care
Retail Health/Urgent Care Module 2: Creating an Environment of Equitable Care
This module developed collaboratively by the National Network of STD Clinical Prevention Training Centers and National Association of County & City Health Officials discusses the concept of gender diversity and needs of LGBTQ+ patients, medical mistrust and equity gaps, and unique aspects of STI care for minors.
Content Lead:
Zoon Wangu, MD, FAAP (she/her)
Associate Professor of Pediatrics, Division of Pediatric Infectious Diseases & Immunology, UMass Chan Medical School & UMass Memorial Children's Medical Center
Clinical Faculty, Sylvie Ratelle STD/HIV Prevention Training Center, Massachusetts Department of Public Health
Contributors:
Kevin L. Ard, MD, MPH (he/him)
Assistant Professor of Medicine, Harvard Medical School
Director, Sexual Health Clinic, Massachusetts General Hospital
Clinical Faculty, Sylvie Ratelle STD/HIV Prevention Training Center, Massachusetts Department of Public Health
Philana Liang, PA-C, MPH, SAFE (she/her)
Division of Infectious Diseases, Washington University School of Medicine
Core Program Manager, St. Louis STI/HIV Prevention Training Center
Alison Marshall, PhD, FNP-C, RN (she/her)
Boston College Connell School of Nursing
Clinical Faculty, Sylvie Ratelle STD/HIV Prevention Training Center, Massachusetts Department of Public Health
Tamara Ooms, RN, MS, FNP (she/her)
University of California San Francisco Bixby Center for Global Reproductive Health
Clinical Faculty and Program Manager, California Prevention Training Center
Duran Rutledge, BA (he/him)
Capacity Building Assistance Trainer and Technical Assistance Specialist, California Prevention Training Center
Katherine Yang, PharmD, MPH (she/her)
Co-Vice Dean, Clinical Innovation and Entrepreneurship
Professor, University of California San Francisco School of Pharmacy
Infectious Diseases Clinical Pharmacist, University of California San Francisco Medical Center
Acknowledgements:
-
Nathan A. Bronstein, MPA, MsED, MSSP (he/him), Chief Operating Officer, Convenient Care Association
-
Rebekah Horowitz, JD, MPH (she/her), Director of STI Programs, National Association of County and City Health Officials
Disclosures:
Our content experts wish to disclose they have no financial relationship(s) with ineligible companies with the exception of Drs. Ard and Wangu. Dr. Ard receives in-kind research support from Binx Health and royalties from McGraw Hill and UpToDate. Dr. Wangu receives royalties from UpToDate, DynaMed, and Elsevier. All relevant financial relationships listed for these individuals have been mitigated.
Tribal Health
Tribal Health Module 1: Series Introduction and Discussing Sexual Health with Patients
This module developed collaboratively by the National Network of STD Clinical Prevention Training Centers and National Association of County & City Health Officials reviews how Tribal Health providers can approach conversations about sexual health with patients, including trauma-informed care, historical and intergenerational trauma, and a holistic and culturally-sensitive approach to health.
Content Lead:
Zoon Wangu, MD, FAAP (she/her)
Associate Professor of Pediatrics, Division of Pediatric Infectious Diseases & Immunology, UMass Chan Medical School & UMass Memorial Children's Medical Center
Clinical Faculty, Sylvie Ratelle STD/HIV Prevention Training Center, Massachusetts Department of Public Health
Contributors:
Kevin L. Ard, MD, MPH (he/him)
Assistant Professor of Medicine, Harvard Medical School
Director, Sexual Health Clinic, Massachusetts General Hospital
Clinical Faculty, Sylvie Ratelle STD/HIV Prevention Training Center, Massachusetts Department of Public Health
Philana Liang, PA-C, MPH, SAFE (she/her)
Division of Infectious Diseases, Washington University School of Medicine
Core Program Manager, St. Louis STI/HIV Prevention Training Center
Alison Marshall, PhD, FNP-C, RN (she/her)
Boston College Connell School of Nursing
Clinical Faculty, Sylvie Ratelle STD/HIV Prevention Training Center, Massachusetts Department of Public Health
Tamara Ooms, RN, MS, FNP (she/her)
University of California San Francisco Bixby Center for Global Reproductive Health
Clinical Faculty and Program Manager, California Prevention Training Center
Duran Rutledge, BA (he/him)
Capacity Building Assistance Trainer and Technical Assistance Specialist, California Prevention Training Center
Katherine Yang, PharmD, MPH (she/her)
Co-Vice Dean, Clinical Innovation and Entrepreneurship
Professor, University of California San Francisco School of Pharmacy
Infectious Diseases Clinical Pharmacist, University of California San Francisco Medical Center
Acknowledgements:
- Jessica Leston (Tsimshian), MPH (she/her), The Raven Collective
- Madalene Mandap, PharmD, BCPS, CPH, AAHIVE (she/her), Integrated Pharmacist, Southcentral Foundation, Anchorage, AK
- Rebekah Horowitz, JD, MPH (she/her), Director of STI Programs, National Association of County and City Health Officials
Disclosures:
Our content experts wish to disclose they have no financial relationship(s) with ineligible companies with the exception of Drs. Ard and Wangu. Dr. Ard receives in-kind research support from Binx Health and royalties from McGraw Hill and UpToDate. Dr. Wangu receives royalties from UpToDate, DynaMed, and Elsevier. All relevant financial relationships listed for these individuals have been mitigated.
Tribal Health
Tribal Health Module 2: Creating an Environment of Equitable Care
This module developed collaboratively by the National Network of STD Clinical Prevention Training Centers and National Association of County & City Health Officials discusses the concept of gender diversity and needs of two-spirit (2S) and LGBTQ+ patients, medical mistrust and equity gaps, and unique aspects of STI care for minors.
Content Lead:
Zoon Wangu, MD, FAAP (she/her)
Associate Professor of Pediatrics, Division of Pediatric Infectious Diseases & Immunology, UMass Chan Medical School & UMass Memorial Children's Medical Center
Clinical Faculty, Sylvie Ratelle STD/HIV Prevention Training Center, Massachusetts Department of Public Health
Contributors:
Kevin L. Ard, MD, MPH (he/him)
Assistant Professor of Medicine, Harvard Medical School
Director, Sexual Health Clinic, Massachusetts General Hospital
Clinical Faculty, Sylvie Ratelle STD/HIV Prevention Training Center, Massachusetts Department of Public Health
Philana Liang, PA-C, MPH, SAFE (she/her)
Division of Infectious Diseases, Washington University School of Medicine
Core Program Manager, St. Louis STI/HIV Prevention Training Center
Alison Marshall, PhD, FNP-C, RN (she/her)
Boston College Connell School of Nursing
Clinical Faculty, Sylvie Ratelle STD/HIV Prevention Training Center, Massachusetts Department of Public Health
Tamara Ooms, RN, MS, FNP (she/her)
University of California San Francisco Bixby Center for Global Reproductive Health
Clinical Faculty and Program Manager, California Prevention Training Center
Duran Rutledge, BA (he/him)
Capacity Building Assistance Trainer and Technical Assistance Specialist, California Prevention Training Center
Katherine Yang, PharmD, MPH (she/her)
Co-Vice Dean, Clinical Innovation and Entrepreneurship
Professor, University of California San Francisco School of Pharmacy
Infectious Diseases Clinical Pharmacist, University of California San Francisco Medical Center
Acknowledgements:
- Jessica Leston (Tsimshian), MPH (she/her), The Raven Collective
- Madalene Mandap, PharmD, BCPS, CPH, AAHIVE (she/her), Integrated Pharmacist, Southcentral Foundation, Anchorage, AK
- Rebekah Horowitz, JD, MPH (she/her), Director of STI Programs, National Association of County and City Health Officials
Disclosures:
Our content experts wish to disclose they have no financial relationship(s) with ineligible companies with the exception of Drs. Ard and Wangu. Dr. Ard receives in-kind research support from Binx Health and royalties from McGraw Hill and UpToDate. Dr. Wangu receives royalties from UpToDate, DynaMed, and Elsevier. All relevant financial relationships listed for these individuals have been mitigated.
This course reviews syphilis screening, how to interpret results and stage disease, and syphilis treatment recommendations based on stage of disease.
At the conclusion of the session, the participant should be able to:
- Describe the diagnostic considerations for syphilis.
- Describe how to treat syphilis.
- Describe the importance of interprofessional collaboration in screening for and treating syphilis.
FACULTY/CREDENTIALS:
Alexandra Filipkowski, BS, MPH candidate (’24), Intern, New York City STD Prevention Training Center
Natalie Neu, MD MPH, Medical Director, NYC STD Prevention Training Center; Associate Professor of Pediatrics/ Fellowship Director, Columbia University Medical Center Pediatric Infectious Disease
Jessica Steinke, MPH, Senior Program Manager, New York City STD Prevention Training Center
Jason Zucker, MD MS, Assistant Professor, Divisions of Adult and Pediatric Infectious Diseases, Columbia University Medical Center; Assistant Medical Director, New York City STD Prevention Training Center
ORIGINATION DATE: April 1, 2024
EXPIRATION DATE: April 1, 2026
HARDWARE/SOFTWARE: Computer Hardware; Internet Connection; Browser
MATERIALS: None
TARGET AUDIENCE: Physicians, Nurse Practitioners, Physician Assistants, Registered Nurses, and other healthcare professionals
PREREQUISITES: Intended for clinicians who provide clinical care for patients with STIs.
FORMAT: This activity is Web-based/Web on Demand.
CONTACT INFORMATION: NYC STD Prevention Training Center, nycptc@cumc.columbia.edu
ACCREDITATION STATEMENTS:
|
|
In support of improving patient care, this activity has been planned and implemented by Centers for Disease Control and Prevention and The NYC STD/HIV Prevention Training Center. The Centers for Disease Control and Prevention is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
|
CME: The Centers for Disease Control and Prevention designates this enduring activity for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CNE: The Centers for Disease Control and Prevention designates this activity for 0.75 nursing contact hours.
CEU: The Centers for Disease Control and Prevention is authorized by IACET to offer 0.1 CEU's for this program.
DISCLOSURE:
In compliance with continuing education requirements, all planners and presenters must disclose all financial relationships, in any amount, with ineligible companies during the previous 24 months as well as any use of unlabeled product(s) or products under investigational use.
CDC, our planners and content experts wish to disclose they have no financial relationship(s) with ineligible companies with the exception of Dr. Barbee and Dr. Neu. Dr. Barbee wishes to disclose research support from Nabriva, Hologic, SpeeDx, and Dr. Neu wishes to disclose research support from Melinta and Cystic Fibrosis Foundation. All relevant financial relationships listed for these individuals have been mitigated.
Content will not include any discussion of the unlabeled use of a product or a product under investigational use.
CDC did not accept financial or in-kind support from ineligible companies for this continuing education activity.
Instructions for Obtaining Continuing Education (CE)
Instructions for claiming CE are provided at the end of this course.
FEES: No fees are charged for CDC’s CE activities.
Grant Statement:
This project is supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award 1 NU62PS924586-01-00 totaling $470,000 with 100 percent funded by CDC/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government.